FDA Inspection 1198157 — Bradley P. Fox, MD
The FDA completed an inspection of Bradley P. Fox, MD on February 16, 2023 in Erie, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Erie, PA (United States)
Additional Details
Clinical Investigator (CI)